VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q91556723 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000232.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q91556723‏
024 ‎‡a 0000-0003-3547-7434‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q91556723‏
100 0 ‎‡a Joon Hyeok Lee‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Joon Hyeok Lee‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels‏
670 ‎‡a Author's Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.‏
670 ‎‡a Author's Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria‏
670 ‎‡a Author's Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread‏
670 ‎‡a Author's Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.‏
670 ‎‡a Author's Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos‏
670 ‎‡a Author's Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients‏
670 ‎‡a Author's Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels‏
670 ‎‡a Author's Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.‏
670 ‎‡a Author's Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma‏
670 ‎‡a Author's Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors‏
670 ‎‡a Author's Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure‏
670 ‎‡a Author's Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up‏
670 ‎‡a Author's The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding‏
909 ‎‡a (orcid) 0000000335477434‏ ‎‡9 1‏
919 ‎‡a prognosticvalueofalphafetoproteininpatientswhoachieveacompleteresponsetotransarterialchemoembolizationforhepatocellularcarcinoma‏ ‎‡A Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma‏ ‎‡9 1‏
919 ‎‡a staticanddynamicprognosticfactorsforhepatitisbrelatedacuteonchronicliverfailure‏ ‎‡A Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure‏ ‎‡9 1‏
919 ‎‡a sustainedefficacyofadjuvantimmunotherapywithcytokineinducedkillercellsforhepatocellularcarcinomaanextended5yearfollowup‏ ‎‡A Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up‏ ‎‡9 1‏
919 ‎‡a roleofradiofrequencyablationinpatientswithhepatocellularcarcinomawhoundergopriortransarterialchemoembolizationlongtermoutcomesandpredictivefactors‏ ‎‡A Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors‏ ‎‡9 1‏
919 ‎‡a comparisonofesophagealvaricealligationpluspropranololversuspropranololalonefortheprimaryprophylaxisofesophagealvaricealbleeding‏ ‎‡A The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding‏ ‎‡9 1‏
919 ‎‡a novelmodelforpredictinghepatocellularcarcinomadevelopmentinpatientswithchronichepatitisbandnormalalanineaminotransferaselevels‏ ‎‡A A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels‏ ‎‡9 1‏
919 ‎‡a clinicalsignificanceandpredictivefactorsofearlymassiverecurrenceafterradiofrequencyablationinpatientswithasinglesmallhepatocellularcarcinoma‏ ‎‡A Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.‏ ‎‡9 1‏
919 ‎‡a comparisonofoutcomebetweenliverresectionradiofrequencyablationandtransarterialtherapyformultiplesmallhepatocellularcarcinomawithinthemilancriteria‏ ‎‡A Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria‏ ‎‡9 1‏
919 ‎‡a differentsurvivalofbarcelonacliniclivercancerstage100hepatocellularcarcinomapatientsbytheextentofportalveininvasionandthetypeofextrahepaticspread‏ ‎‡A Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread‏ ‎‡9 1‏
919 ‎‡a hepatocellularcarcinomariskofcompensatedcirrhosispatientswithelevatedhbvdnalevelsaccordingtoserumaminotransferaselevels‏ ‎‡A Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.‏ ‎‡9 1‏
919 ‎‡a longtermefficacyoftenofovirdisoproxilfumaratetherapyaftermultiplenucleos‏ ‎‡A Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos‏ ‎‡9 1‏
919 ‎‡a longtermefficacyoftenofovirdisoproxilfumaratetherapyaftermultiplenucleostideanaloguefailureinchronichepatitisbpatients‏ ‎‡A Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients‏ ‎‡9 1‏
919 ‎‡a predictionofclinicaloutcomesinhepatitisbeantigennegativechronichepatitisbpatientswithelevatedhepatitisbvirusdnalevels‏ ‎‡A Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels‏ ‎‡9 1‏
919 ‎‡a predictionoftheriskofhepatocellularcarcinomainchronichepatitis100patientsaftersustainedvirologicalresponsebyaspartateaminotransferasetoplateletratioindex‏ ‎‡A Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000463649122
996 ‎‡2 ISNI|0000000473806339
996 ‎‡2 ISNI|0000000430327266
996 ‎‡2 ISNI|0000000463403376
996 ‎‡2 LC|no2021122727
996 ‎‡2 ISNI|0000000377491859
996 ‎‡2 BIBSYS|8056206
996 ‎‡2 BNF|12536294
996 ‎‡2 BIBSYS|90362303
996 ‎‡2 ISNI|0000000463328871
996 ‎‡2 LC|no2009100070
996 ‎‡2 LC|n 84218241
996 ‎‡2 J9U|987007375967705171
996 ‎‡2 LC|n 2015028413
996 ‎‡2 ISNI|0000000483483414
996 ‎‡2 ISNI|0000000493004202
996 ‎‡2 ISNI|000000050499189X
996 ‎‡2 ISNI|0000000465082115
996 ‎‡2 J9U|987007297153905171
996 ‎‡2 ISNI|0000000467985502
996 ‎‡2 ISNI|0000000491938298
996 ‎‡2 ISNI|0000000464671524
996 ‎‡2 ISNI|0000000476677413
996 ‎‡2 ISNI|0000000467762106
996 ‎‡2 BNC|981058525074806706
996 ‎‡2 ISNI|000000010997319X
996 ‎‡2 ISNI|0000000468318496
996 ‎‡2 LC|nr2004016763
996 ‎‡2 ISNI|0000000459352799
996 ‎‡2 ISNI|000000007587319X
996 ‎‡2 PLWABN|9810690524305606
996 ‎‡2 ISNI|0000000463403085
996 ‎‡2 LC|n 2018015698
996 ‎‡2 ISNI|0000000074783088
996 ‎‡2 ISNI|0000000494021215
996 ‎‡2 ISNI|0000000493281314
996 ‎‡2 BNF|14406379
996 ‎‡2 ISNI|0000000512350355
996 ‎‡2 DNB|1025994000
996 ‎‡2 ISNI|0000000493249744
996 ‎‡2 CAOONL|ncf11674131
996 ‎‡2 ISNI|0000000478638901
996 ‎‡2 ISNI|0000000464920949
996 ‎‡2 SUDOC|243280955
996 ‎‡2 LC|n 2014006920
996 ‎‡2 LC|nr 93040741
996 ‎‡2 ISNI|0000000461035784
996 ‎‡2 CAOONL|ncf10309384
996 ‎‡2 ISNI|0000000474763975
996 ‎‡2 ISNI|0000000465014702
996 ‎‡2 ISNI|0000000024894388
996 ‎‡2 ISNI|0000000512505193
996 ‎‡2 LC|n 2014186643
996 ‎‡2 ISNI|0000000464699471
996 ‎‡2 ISNI|0000000473929929
996 ‎‡2 SUDOC|16659086X
996 ‎‡2 ISNI|0000000381998759
996 ‎‡2 ISNI|0000000468741307
996 ‎‡2 ISNI|0000000479114261
996 ‎‡2 LC|nr 00009929
996 ‎‡2 ISNI|000000008333839X
996 ‎‡2 ISNI|000000047393914X
996 ‎‡2 ISNI|0000000473563648
996 ‎‡2 ISNI|000000047367310X
996 ‎‡2 ISNI|0000000493287046
996 ‎‡2 ISNI|0000000492097507
996 ‎‡2 SUDOC|268658633
996 ‎‡2 ISNI|0000000464690581
996 ‎‡2 ISNI|0000000504590375
996 ‎‡2 ISNI|0000000505358607
996 ‎‡2 LIH|LNB:C_z_KA;=B_f_
996 ‎‡2 ISNI|0000000073416374
996 ‎‡2 ISNI|0000000479153607
996 ‎‡2 SUDOC|234300280
996 ‎‡2 ISNI|0000000504501678
996 ‎‡2 SUDOC|031953999
996 ‎‡2 ISNI|0000000505449883
996 ‎‡2 ISNI|0000000464634707
996 ‎‡2 SUDOC|147906083
996 ‎‡2 BNF|16530004
996 ‎‡2 ISNI|0000000474106721
996 ‎‡2 ISNI|0000000512314477
996 ‎‡2 NUKAT|n 2011103895
996 ‎‡2 ISNI|0000000464192486
996 ‎‡2 DNB|12303485X
996 ‎‡2 DBC|87097969571573
996 ‎‡2 ISNI|0000000512353812
996 ‎‡2 LC|no2023106017
996 ‎‡2 ISNI|0000000502737281
996 ‎‡2 ISNI|0000000464463637
996 ‎‡2 DNB|1081993359
996 ‎‡2 ISNI|0000000464802774
996 ‎‡2 ISNI|0000000032060543
996 ‎‡2 ISNI|000000046873828X
996 ‎‡2 ISNI|000000047681852X
996 ‎‡2 NTA|29878789X
996 ‎‡2 ISNI|0000000474007176
996 ‎‡2 CAOONL|ncf10119647
996 ‎‡2 LC|no2002043511
996 ‎‡2 ISNI|0000000494013143
996 ‎‡2 NUKAT|n 2003033233
996 ‎‡2 ISNI|0000000460132793
996 ‎‡2 ISNI|0000000492996596
996 ‎‡2 DNB|1124101349
996 ‎‡2 ISNI|0000000464885696
996 ‎‡2 ISNI|000000049241199X
996 ‎‡2 ISNI|0000000464933627
996 ‎‡2 LC|no2009006927
996 ‎‡2 BIBSYS|15014226
996 ‎‡2 NUKAT|n 2006098626
996 ‎‡2 ISNI|0000000492428951
996 ‎‡2 ISNI|0000000493249795
996 ‎‡2 LC|n 80102639
996 ‎‡2 SUDOC|243288700
996 ‎‡2 DNB|127933816
996 ‎‡2 NTA|129747440
996 ‎‡2 ISNI|0000000467874685
996 ‎‡2 ISNI|0000000459349055
996 ‎‡2 ISNI|0000000504613768
996 ‎‡2 BIBSYS|3070312
996 ‎‡2 LC|n 90687677
996 ‎‡2 ISNI|0000000512328879
996 ‎‡2 SUDOC|119722348
996 ‎‡2 ISNI|0000000474239022
996 ‎‡2 ISNI|0000000463534536
996 ‎‡2 ISNI|0000000492893511
996 ‎‡2 ISNI|0000000492134259
996 ‎‡2 DNB|1245091611
996 ‎‡2 ISNI|0000000483713902
996 ‎‡2 ISNI|0000000461090011
996 ‎‡2 ISNI|000000046772373X
996 ‎‡2 ISNI|0000000023551287
996 ‎‡2 LC|n 83161621
996 ‎‡2 PLWABN|9810571477105606
996 ‎‡2 ISNI|0000000480090017
996 ‎‡2 ISNI|0000000493166252
996 ‎‡2 LC|n 88614502
996 ‎‡2 ISNI|0000000448100975
996 ‎‡2 BIBSYS|90276147
996 ‎‡2 ISNI|0000000467848102
996 ‎‡2 ISNI|0000000513323201
996 ‎‡2 ISNI|000000049322386X
996 ‎‡2 ISNI|0000000475254531
996 ‎‡2 BIBSYS|12007431
996 ‎‡2 CYT|AC000123046
996 ‎‡2 J9U|987007345551005171
996 ‎‡2 ISNI|0000000505964439
996 ‎‡2 ISNI|0000000407765049
996 ‎‡2 ISNI|0000000459449494
996 ‎‡2 SUDOC|151255326
996 ‎‡2 PLWABN|9810570744005606
996 ‎‡2 ISNI|0000000465062608
996 ‎‡2 ISNI|0000000468814182
996 ‎‡2 DNB|1075083362
996 ‎‡2 DNB|128876557
996 ‎‡2 ISNI|0000000493249752
996 ‎‡2 ISNI|0000000513307586
996 ‎‡2 ISNI|0000000473689670
996 ‎‡2 ISNI|0000000491591802
996 ‎‡2 ISNI|0000000483866749
996 ‎‡2 CAOONL|ncf11594295
996 ‎‡2 ISNI|0000000467740089
996 ‎‡2 ISNI|0000000511205965
996 ‎‡2 DNB|1024388573
996 ‎‡2 DNB|1279737816
996 ‎‡2 NKC|ntk2011658535
996 ‎‡2 ISNI|0000000493986226
996 ‎‡2 ISNI|0000000504160885
996 ‎‡2 ISNI|0000000492990020
996 ‎‡2 LC|no2014055926
996 ‎‡2 LC|no2007119412
996 ‎‡2 J9U|987007592128105171
996 ‎‡2 CAOONL|ncf11514487
996 ‎‡2 ISNI|0000000055580082
996 ‎‡2 ISNI|0000000477231122
996 ‎‡2 SUDOC|280101848
996 ‎‡2 ISNI|0000000473991175
996 ‎‡2 DNB|138532907
996 ‎‡2 ISNI|0000000473712420
996 ‎‡2 ISNI|0000000495493417
996 ‎‡2 ISNI|0000000504945412
996 ‎‡2 NDL|001109589
996 ‎‡2 ISNI|0000000479151345
996 ‎‡2 PLWABN|9810558831005606
996 ‎‡2 LC|n 80094424
996 ‎‡2 RERO|A003507220
996 ‎‡2 RERO|A003507221
996 ‎‡2 BNE|XX5671065
996 ‎‡2 ISNI|0000000477559494
996 ‎‡2 ISNI|0000000493194253
996 ‎‡2 ISNI|0000000503888380
996 ‎‡2 ISNI|0000000467605389
996 ‎‡2 CAOONL|ncf11574073
996 ‎‡2 ISNI|0000000516897497
996 ‎‡2 ISNI|0000000492439810
996 ‎‡2 LC|no2001069856
996 ‎‡2 ISNI|0000000467762739
996 ‎‡2 ISNI|0000000468730464
996 ‎‡2 SUDOC|093543859
996 ‎‡2 CAOONL|ncf10882333
996 ‎‡2 B2Q|0000122847
996 ‎‡2 ISNI|0000000492077821
996 ‎‡2 CAOONL|ncf10193906
996 ‎‡2 BIBSYS|7058374
996 ‎‡2 DNB|135737907
996 ‎‡2 ISNI|0000000467986871
996 ‎‡2 LC|n 80126407
996 ‎‡2 LIH|LNB:C_y__l__q_;=C_j_
996 ‎‡2 BIBSYS|90150658
996 ‎‡2 ISNI|0000000461011096
996 ‎‡2 ISNI|0000000505440133
996 ‎‡2 ISNI|0000000491601273
996 ‎‡2 BIBSYS|90233075
996 ‎‡2 NTA|06824584X
996 ‎‡2 PLWABN|9811239848005606
996 ‎‡2 LC|n 85035406
996 ‎‡2 PLWABN|9810597976005606
996 ‎‡2 ISNI|0000000505248635
996 ‎‡2 SUDOC|124363008
996 ‎‡2 NII|DA10852018
996 ‎‡2 J9U|987007423360705171
996 ‎‡2 ISNI|0000000463314349
996 ‎‡2 ISNI|000000046798530X
996 ‎‡2 ISNI|0000000493281330
996 ‎‡2 ISNI|0000000513456063
996 ‎‡2 ISNI|0000000464608058
996 ‎‡2 RERO|A003507219
996 ‎‡2 ISNI|0000000463356303
996 ‎‡2 SUDOC|183524934
996 ‎‡2 DNB|1280920297
996 ‎‡2 LC|no2010160834
996 ‎‡2 DNB|122658795
996 ‎‡2 ISNI|0000000473996582
996 ‎‡2 LC|no2011112425
996 ‎‡2 ISNI|0000000465163548
996 ‎‡2 LC|no2011130478
996 ‎‡2 ISNI|0000000503881605
996 ‎‡2 ISNI|000000046776286X
996 ‎‡2 ISNI|0000000475249580
996 ‎‡2 ISNI|000000004959869X
996 ‎‡2 ISNI|0000000465183792
996 ‎‡2 DNB|1321794746
996 ‎‡2 ISNI|0000000492056078
996 ‎‡2 ISNI|0000000513322540
996 ‎‡2 ISNI|0000000465184234
996 ‎‡2 NUKAT|n 2016173616
996 ‎‡2 BIBSYS|98029465
996 ‎‡2 ISNI|0000000492076490
996 ‎‡2 ISNI|0000000117310302
996 ‎‡2 ISNI|0000000464202269
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏